AMN Healthcare Services Inc. (AMN): What Does Valuation Ratios Tell Us?

AMN Healthcare Services Inc. (NYSE:AMN) saw an upside of 1.55% to close Friday at $89.16 after adding $1.36 on the day. The 5-day average trading volume is 538,120 shares of the company’s common stock. It has gained $91.57 in the past week and touched a new high 3 times within the past 5 days. An average of 884,365 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 712,194.

AMN’s 1-month performance is -20.17% or -$20.70 on its low of $86.53 reached on 08/17/23. The company’s shares have touched a 52-week low of $81.15 and high of $129.04, with the stock’s rally to the 52-week high happening on 01/11/23. YTD, AMN has lost -13.29% or -$13.66 and has reached a new high 6 times. However, the current price is down -30.91% from the 52-week high price.

Insider Transactions

AMN stock investors last saw insider trading activity on Jun 14.Jones Daphne E (Director) most recently sold 1,000 shares at $109.57 per share on Jun 14. This transaction cost the insider $109,570. Director, FOLETTA MARK G, sold 1,458 shares at a price of $88.78 on Apr 21. Then, on Apr 11, Director FOLETTA MARK G sold 6,042 shares at a price of $84.35 per share. This transaction amounted to $509,638.

Valuation Metrics

AMN stock has a beta of 0.44. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.76 while the price-to-book (PB) in the most recent quarter is 4.56, with the price to cash flow ratio at 8.84.

AMN Healthcare Services Inc.’s quick ratio for the period ended June 29 was 1.20, with the current ratio over the same period at 1.20. As well, the company’s long term debt to equity for the quarter ending June 29 was 1.35, while the total debt to equity was 1.35. In terms of profitability, the gross margin trailing 12 months is 33.30%. The trailing 12-month EBITDA margin is 14.90% while for the period ending June 29, AMN Healthcare Services Inc.’s operating margin was 10.80%. The firm’s gross profit as reported stood at $1.72 billion against revenue of $5.24 billion.

Earnings Surprise

For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -103.25% to $60.91 million, while revenue of $84.11 million was -38.09% off the previous quarter. Analysts expected AMN to announce $2.14 per share in earnings in its latest quarter, but it posted $2.38, representing a 11.20% surprise. EBITDA for the quarter stood at more than $129.9 million. AMN stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 1.88 billion, with total debt at $1.07 billion. Shareholders hold equity totaling $37.99 million.

Let’s look briefly at AMN Healthcare Services Inc. (AMN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 31.03% to suggest the stock is trending Neutral, with historical volatility in this time period at 26.10%.

The stock’s 5-day moving average is $88.97, reflecting a -0.72% or -$0.65 change from its current price. AMN is currently trading -19.72% above its 20-day SMA, +4.31% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -15.21% and SMA200 by-28.96%.

Stochastic %K and %D was 6.22% and 6.29% and the average true range (ATR) pointed at 2.98. The RSI (14) points at 31.80%, while the 14-day stochastic is at 12.10% with the period’s ATR at 3.05. The stock’s 9-day MACD Oscillator is pointing at -1.53 and -4.92 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for AMN Healthcare Services Inc. (NYSE: AMN), BofA Securities downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for AMN stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate AMN as a “sell,”, while 3 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 6 have offered a “buy” rating.

Most Popular

Related Posts